Providing must-have knowledge for the pharmaceutical industry and process chemists in industry, this ready reference offers solutions for saving time and money and supplying -- in a sustainable way -- valuable products. Application-oriented and well structured, each chapter presents successful strategies for the latest modern drugs, showing how to provide very fast bulk quantities of drug candidates. Throughout, the text illustrates how all the key factors are interwoven and dependent on one another in creating optimized methods for optimal products.
NOBUYASHI YASUDA received his bachelor's degree from Tokyo Institute of Technology under the direction of Professors Teruaki Mukaiyama and Hisashi Takei and his mater degree from the same university under the direction of Professor Takei. After working at Fujisawa Pharmaceutical Company, Japan, as a Medicinal Chemist, he received PhD from Tokyo Institute of Technology in 1987. After spending one year as a postdoctoral fellow under Professor Robert M. Williams at Colorado State University from 1988 to 1989, he joined Process Chemistry, Merck Research Laboratories in 1990. He has over 60 publications and over 50 patents.
Preface Efavirenz(R), a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), and a Previous Structurally Related Development Candidate CCR5 Receptor Antagonist 5a-Reductase Inhibitors - The Finasteride Story Rizatriptan (Maxalt(R)): A 5-HT1D Receptor Agonist SERM: Selective Estrogen Receptor Modulator HIV Integrase Inhibitor: Raltegravir Cyclopentane-Based NK1 Receptor Antagonist Glucokinase Activator CB1R Inverse Agonist - Taranabant